Employing a targeted delivery technique that exploits reactive astrocytosis to deliver regionally specific IGF-1 in a delayed fashion after TBI, we demonstrate for the first time that IGF-1 provides hippocampal neuroprotection in addition to improving cognitive and motor function following brain injury. The gene discussed is IGF1; the disease is brain injury.